Mohamed Abouelkhair | Microbiology | Best Researcher Award

Published on by Environmental Scientists

Assoc. Prof. Dr. Mohamed Abouelkhair | Microbiology | Best Researcher Award

Associate professor, Rowan University New Jersey, United States.                    

Dr. Mohamed Abouelkhair 🇺🇸 is an accomplished immunologist and virologist with expertise in Staphylococcus research, vaccine development, and flow cytometry. Currently serving as Associate Professor of Virology and Clinical Immunology at Rowan University, he has built an impressive career spanning both the U.S. and Egypt. Dr. Abouelkhair has contributed significantly to microbiology and immunology through research, teaching, and scientific service.

Professional Profile

Scopus

Google Scholar

Orcid

🎓 Education

Dr. Abouelkhair holds a PhD in Biomedical and Diagnostic Medicine (2019) from the University of Tennessee, USA. He earned his Master’s degree in Bacteriology, Mycology, and Immunology (2013) and Bachelor’s degree (2009) from University of Sadat City, Egypt. His academic journey showcases a strong foundation in microbiology, infectious diseases, and immunology.

💼 Experience

With over a decade of professional experience, Dr. Abouelkhair has held positions at leading institutions. He has worked as a Postdoctoral Research Associate and Assistant Professor at the University of Tennessee, contributing to experimental medicine and immunology research. His career also includes roles at University of Sadat City, and currently, he is a founding faculty member at Rowan University’s Department of Diagnostic Medicine & Pathobiology.

🔬 Research Interests

Dr. Abouelkhair’s research interests focus on immunology, virology, vaccine development, microbial genomics, and flow cytometry. He is deeply involved in studying Staphylococcus species, zoonotic diseases, and antimicrobial resistance, with a goal to advance diagnostic tools and preventive strategies for infectious diseases.

🏆 Awards

Throughout his career, Dr. Abouelkhair has received numerous honors, including the Phi Zeta Veterinary Honor Society Award, several travel grants for prestigious conferences like ASM Microbe and Nature Conference, and a four-year PhD scholarship from the Egyptian Cultural and Educational Bureau. He is also recognized for his scientific reviewing and service roles in journals and professional organizations.

📚 Top Noted Publications

Genome Mining Reveals a Sactipeptide Biosynthetic Cluster in Staphylococcus pseudintermedius (Veterinary Sciences, 2025).

Genome sequence of a bovine respiratory syncytial virus strain from a cow in Tennessee (Microbiology Resource Announcements, 2025).

Pathology and parasitology of free-ranging coyotes from Tennessee and South Carolina (PLOS ONE, 2025).

Whole Genome Sequencing and Comparative Genomics of Six Staphylococcus schleiferi and Staphylococcus coagulans Isolates (Genes, 2024).

Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 patients (PeerJ, 2020).

Conclusion

Dr. Mohamed Abouelkhair is a highly deserving candidate for the Best Researcher Award. His multidisciplinary expertise, prolific publication record, innovative genomic studies, and leadership in research make him an excellent choice. With continued advancement in grant acquisition and broader collaborations, his future contributions are likely to become even more influential in the fields of infectious diseases and immunology.

Hayriye Kırkoyun Uysal | Medical Microbiology | Best Researcher Award

Published on by Environmental Scientists

Assoc. Prof. Dr. Hayriye Kırkoyun Uysal | Medical Microbiology | Best Researcher Award

Assoc.Prof.Dr./Academician, Istanbul University Istanbul Medical Faculty, Turkey 📝

Dr. Hayriye Kırkoyun Uysal is a distinguished researcher and academic affiliated with Istanbul Medical Faculty, Istanbul University, Turkey. Her expertise spans microbiology, infectious diseases, and molecular diagnostics. With numerous peer-reviewed publications, she has made significant contributions to virology, epidemiology, and diagnostic innovations. Dr. Uysal is actively involved in groundbreaking studies on SARS-CoV-2, Epstein-Barr virus, and other infectious agents, shaping the future of clinical microbiology.

Profile

Orcid

Education 🎓

Dr. Uysal completed her medical education at Istanbul Medical Faculty, Istanbul University, Turkey, where she gained extensive knowledge in clinical microbiology and infectious diseases. Her academic journey reflects a strong foundation in diagnostic methodologies, virology, and immunology, preparing her for a career at the intersection of research and clinical applications.

Professional Experience 💼

Dr. Hayriye Kırkoyun Uysal is currently employed at Istanbul Medical Faculty, Istanbul University, where she is engaged in clinical research, diagnostic microbiology, and infectious disease investigations. She collaborates with multidisciplinary teams to advance diagnostic technologies and public health interventions. Her work includes pioneering research in molecular virology and serological diagnostics.

Research Interests 🔬

Dr. Hayriye Kırkoyun Uysal’s research focuses on virology, molecular diagnostics, and infectious diseases, with a strong emphasis on improving diagnostic methodologies and understanding viral pathogenesis. She is particularly interested in congenital cytomegalovirus infections, exploring their impact on maternal and fetal health. Her work on SARS-CoV-2 epidemiology and immunology provides valuable insights into infection patterns, immunity development, and vaccine effectiveness. She is also engaged in the development of microfluidic diagnostic devices, integrating cutting-edge technology for rapid and precise pathogen detection. Additionally, her studies on Parvovirus B19 and Epstein-Barr virus contribute to the understanding of their clinical, molecular, and serological characteristics. Her expertise extends to respiratory tract virus surveillance, analyzing the spread and mutation patterns of viral infections to enhance public health strategies. By combining molecular techniques, serological analysis, and epidemiological insights, Dr. Uysal plays a crucial role in advancing infectious disease diagnostics and control.

Awards & Recognitions 🏆

Dr. Uysal has received recognition for her contributions to virology and molecular diagnostics. Her research on SARS-CoV-2 immunity, microfluidic diagnostic technologies, and viral infections in immunocompromised patients has been widely cited, reflecting her impact on global infectious disease research.

Publications 📚

Evaluation of Congenital Cytomegalovirus Infection in Pregnant Women (2024) – Viruses
DOI: 10.3390/v16030414 | Cited by: –

Fabrication of a Microfluidic Test Device for Streptococcus pyogenes Detection (2024) – Micromachines
DOI: 10.3390/mi15030365 | Cited by: –

Protection Against SARS-CoV-2 After Booster Vaccination (2024) – SSRN
DOI: 10.2139/ssrn.4777941 | Cited by: –

Role of Clinical, Molecular, and Serological Features in Parvovirus B19 Diagnosis (2024) – Diagnostic Microbiology and Infectious Disease
DOI: 10.1016/J.DIAGMICROBIO.2024.116300 | Cited by: –

Epstein-Barr Virus in Oral Lichen Planus & Contact Lesions (2024) – Northern Clinics of Istanbul
DOI: 10.14744/nci.2024.63239 | Cited by: –

Effect of COVID-19 Pandemic on Respiratory Viruses in Turkey (2024) – Infectious Disease Reports
DOI: 10.3390/idr16050079 | Cited by: –

Antibody Responses Post-Booster COVID-19 Vaccination (2024) – Diagnostic Microbiology and Infectious Disease
DOI: 10.1016/j.diagmicrobio.2024.116425 | Cited by: –

Evaluation of SARS-CoV-2-Positive Patients with Suspected Reinfection (2023) – Viruses
DOI: 10.3390/v15112222 | Cited by: –

Conclusion

Dr. Hayriye Kırkoyun Uysal’s research is groundbreaking, highly impactful, and aligns perfectly with the criteria for the Best Researcher Award. Her ability to address complex diagnostic and infectious disease challenges, along with her innovative research contributions, make her an excellent candidate for this award. Expanding her influence through broader international research collaborations could further amplify her impact on global healthcare.